Last updated: 15 March 2024 at 4:56pm EST

Laurie Glimcher Net Worth




The estimated Net Worth of Laurie H M.D. Glimcher is at least $2.72 Millón dollars as of 8 March 2024. Laurie Glimcher owns over 1,228 units of Analog Devices stock worth over $1,070,883 and over the last 19 years he sold ADI stock worth over $1,652,430. In addition, he makes $0 as Independent Director at Analog Devices.

Laurie Glimcher ADI stock SEC Form 4 insiders trading

Laurie has made over 20 trades of the Analog Devices stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,228 units of ADI stock worth $276,386 on 8 March 2024.

The largest trade he's ever made was exercising 11,000 units of Analog Devices stock on 30 January 2013 worth over $281,600. On average, Laurie trades about 1,141 units every 82 days since 2006. As of 8 March 2024 he still owns at least 4,758 units of Analog Devices stock.

You can see the complete history of Laurie Glimcher stock trades at the bottom of the page.





Laurie Glimcher biography

Dr. Laurie H. Glimcher M.D. serves as Independent Director of the Company. Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to the medical literature. She also currently serves on the Board of Directors at GlaxoSmithKline Pharmaceutical Corporation. In addition to a number of senior leadership roles held at both Harvard Medical School and Harvard School of Public Health from 1982 to present, she has also served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. She is a member of the Board of Trustees at the Dana-Farber Cancer Institute and a member of the US National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. She previously served on the Board of Directors of Bristol-Myers Squibb Pharmaceutical Corporation and Waters Corporation. She is also the recipient of many awards and honors. In 2018, she received the American Association of Immunologists Lifetime Achievement Award; the Indiana University School of Medicine's Steven C. Beering Award for outstanding research contributions to advancement of biomedical or clinical science; and the L'Oréal-UNESCO Award for Women in Science. She has also received the 2017 George M. Kober Medal and the 2017 Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC). Dr. Glimcher is a magna cum laude graduate of Radcliffe College, and holds an MD degree cum laude from Harvard Medical School.



How old is Laurie Glimcher?

Laurie Glimcher is 68, he's been the Independent Director of Analog Devices since 2020. There are 4 older and 22 younger executives at Analog Devices. The oldest executive at Analog Devices Inc. is Dr. Raymond S. Stata Ph.D., 87, who is the Founder & Chairman.

Insiders trading at Analog Devices

Over the last 23 years, insiders at Analog Devices have traded over $165,706,606 worth of Analog Devices stock and bought 79,667 units worth $7,085,991 . The most active insiders traders include Bruce R Evans, Lisa T Su y Tracy S Keogh. On average, Analog Devices executives and independent directors trade stock every 9 days with the average trade being worth of $2,266,230. The most recent stock trade was executed by Vincent Roche on 3 September 2024, trading 10,000 units of ADI stock currently worth $911,300.



What does Analog Devices do?

Analog Devices, Inc., also known simply as Analog, is an American multinational semiconductor company specializing in data conversion, signal processing, and power management technology, headquartered in Wilmington, Massachusetts.



What does Analog Devices's logo look like?

Analog Devices Inc. logo

Complete history of Laurie Glimcher stock trades at Analog Devices, Bristol-Myers Squibb Co y Waters

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
8 Mar 2024 Laurie H M.D. Glimcher
Director
Uso de opción 1,228 $195.94 $240,614
8 Mar 2024
4,758
8 Mar 2023 Laurie H M.D. Glimcher
Director
Uso de opción 1,495 $186.57 $278,922
8 Mar 2023
3,530
9 Mar 2022 Laurie H M.D. Glimcher
Director
Uso de opción 1,435 $153.62 $220,445
9 Mar 2022
2,035
16 Mar 2021 Laurie H M.D. Glimcher
Director
Venta 460 $154.07 $70,872
16 Mar 2021
600
10 Mar 2021 Laurie H M.D. Glimcher
Director
Uso de opción 1,060 $147.11 $155,937
10 Mar 2021
1,060
1 Nov 2019 Laurie H M.D. Glimcher
Director
Venta 2,200 $214.64 $472,208
1 Nov 2019
3,600
26 Feb 2019 Laurie H M.D. Glimcher
Director
Venta 1,485 $238.69 $354,455
26 Feb 2019
5,800
19 May 2017 Laurie H M.D. Glimcher
Director
Uso de opción 4,800 $86.58 $415,584
19 May 2017
7,649
28 Jul 2016 Laurie H M.D. Glimcher
Director
Uso de opción 4,000 $76.37 $305,480
28 Jul 2016
12,961
1 May 2015 Laurie H M.D. Glimcher
Director
Uso de opción 4,000 $74.81 $299,240
1 May 2015
9,200
29 Jul 2014 Laurie H M.D. Glimcher
Director
Venta 5,500 $105.65 $581,075
29 Jul 2014
4,000
13 Feb 2014 Laurie H M.D. Glimcher
Director
Uso de opción 2,900 $63.25 $183,425
13 Feb 2014
10,900
8 Nov 2013 Laurie H M.D. Glimcher
Director
Uso de opción 2,400 $61.63 $147,912
8 Nov 2013
10,400
25 Jan 2013 Laurie H M.D. Glimcher
Director
Uso de opción 6,800 $44.44 $302,192
25 Jan 2013
10,800
6 Nov 2012 Laurie H M.D. Glimcher
Director
Uso de opción 1,000 $38.10 $38,100
6 Nov 2012
7,500
9 May 2012 Laurie H M.D. Glimcher
Director
Uso de opción 2,000 $38.10 $76,200
9 May 2012
8,500
13 May 2011 Laurie H M.D. Glimcher
Director
Uso de opción 6,900 $53.73 $370,737
13 May 2011
11,900
8 Mar 2011 Laurie H M.D. Glimcher
Director
Venta 2,000 $86.91 $173,820
8 Mar 2011
5,000
30 Jan 2013 Laurie H M.D. Glimcher
Director
Uso de opción 11,000 $25.60 $281,600
30 Jan 2013
11,000
16 Mar 2012 Laurie H M.D. Glimcher
Director
Uso de opción 3,500 $28.38 $99,330
16 Mar 2012
3,500


Analog Devices executives and stock owners

Analog Devices executives and other stock owners filed with the SEC include: